We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 522

USPTO to host roundtable on harmonization of substantive patent law

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

The U.S. Patent and Trademark Office (USPTO) will host a November 19, 2014, roundtable in Alexandria, Virginia, on the international harmonization of

Non-practicing entity’s suit to halt FTC investigation dismissed

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

A federal court in Texas has dismissed for lack of standing and ripeness and for failure to exhaust administrative remedies a declaratory judgment

Newsbytes

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

The U.S. Patent and Trademark Office extends the deadline for applications under its Patents for Humanity Program, "which recognizes patent holders

Public watchdog calls on FDA to issue “revolving door” guidance

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

Public Citizen recently called on the U.S. Food and Drug Administration (FDA) to take certain steps that would both prohibit the practice of advisory

Shire Pharmaceuticals settles FCA claims for $56.5 million

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

Without admitting liability, Wayne, Pennsylvania-based Shire Pharmaceuticals LLC has entered a settlement agreement with the U.S. Department of

FDA contends Twitter not off limits for pharmaceutical cos.

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • October 2 2014

While the U.S. Food and Drug Administration (FDA) has extended the deadline for comments on its draft guidance for drug and medical device makers

Australian court finds human gene mutation to be patentable

  • Shook Hardy & Bacon LLP
  • -
  • Australia, USA
  • -
  • September 11 2014

A full panel of the Federal Court of Australia has upheld its earlier ruling that an isolated but naturally occurring nucleic acid, BRCA1, can be

Vaccine developer agrees to settle shareholder litigation

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

A putative class action instituted by three shareholders against the nowbankrupt biotechnology company Biovest International, Inc., alleging

International funding agencies to support infectious disease research

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

Under the Ecology and Evolution of Infectious Diseases program, three U.S. agenciesthe National Institutes of Health (NIH), National Science

FDA releases clinical trial action plan

  • Shook Hardy & Bacon LLP
  • -
  • USA
  • -
  • September 11 2014

The U.S. Food and Drug Administration (FDA) has issued a 27-point action plan aimed at improving diversity in clinical trials. While the numbers of